Related references
Note: Only part of the references are listed.Agonist potency at P2X7 receptors is modulated by structurally diverse lipids
A. D. Michel et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Effect of the purinergic receptor P2X7 on Chlamydia infection in cervical epithelial cells and vaginally infected mice
Toni Darville et al.
JOURNAL OF IMMUNOLOGY (2007)
Lysophosphatidy1choline potentiates Ca2+ influx, pore formation and p44/42 MAP kinase phosphorylation mediated by P2X7 receptor activation in mouse microglial cells
Takato Takenouchi et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Antimicrobial peptides human β-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines
Francois Niyonsaba et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Cathelicidin antimicrobial peptides block dendritic cell TLR4 activation and allergic contact sensitization
Anna Di Nardo et al.
JOURNAL OF IMMUNOLOGY (2007)
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
Robert E. W. Hancock et al.
NATURE BIOTECHNOLOGY (2006)
A role for P2X7 in microglial proliferation
Fabio Bianco et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Pannexin-1 mediates large pore formation and interleukin-1β release by the ATP-gated P2X7 receptor
Pablo Pelegrin et al.
EMBO JOURNAL (2006)
Evolution of the primate cathelicidin - Correlation between structural variations and antimicrobial activity
Igor Zelezetsky et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria
O Cirioni et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7
Isao Nagaoka et al.
JOURNAL OF IMMUNOLOGY (2006)
Mechanistic and functional studies of the interaction of a proline-rich antimicrobial peptide with mammalian cells
L Tomasinsig et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Potentiation of native and recombinant P2X7-mediated calcium signaling by arachidonic acid in cultured cortical astrocytes and human embryonic kidney 293 cells
Susanna Alloisio et al.
MOLECULAR PHARMACOLOGY (2006)
Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37
S Tokumaru et al.
JOURNAL OF IMMUNOLOGY (2005)
Controlled alteration of the shape and conformational stability of α-helical cell-lytic peptides:: effect on mode of action and cell specificity
I Zelezetsky et al.
BIOCHEMICAL JOURNAL (2005)
Alarmins: chemotactic activators of immune responses
JJ Oppenheim et al.
CURRENT OPINION IN IMMUNOLOGY (2005)
Basal activation of the P2X7 ATP receptor elevates mitochondrial calcium and potential, increases cellular ATP levels, and promotes serum-independent growth
E Adinolfi et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
Antimicrobial protein hCAP18/LL-37 is highly expressed in breast cancer and is a putative growth factor for epithelial cells
JD Heilborn et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Structure-function relationships among human cathelicidin peptides: Dissociation of antimicrobial properties from host immunostimulatory activities
MH Braff et al.
JOURNAL OF IMMUNOLOGY (2005)
D-enantiomer peptide of the TCRα transmembrane domain inhibits T-cell activation in vitro and in vivo
D Gerber et al.
FASEB JOURNAL (2005)
The cathelicidins - Structure, function and evolution
L Tomasinsig et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2005)
A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1β processing and release
A Elssner et al.
JOURNAL OF IMMUNOLOGY (2004)
The antibiotic polymyxin B modulates P2X7 receptor function
D Ferrari et al.
JOURNAL OF IMMUNOLOGY (2004)
Perturbation of the hydrophobic core of lipid bilayers by the human antimicrobial peptide LL-37
KA Henzler-Wildman et al.
BIOCHEMISTRY (2004)
Hetero-assembly between all-L- and all-D-amino acid transmembrane domains: Forces involved and implication for inactivation of membrane proteins
N Sal-Man et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Cathelicidins, multifunctional peptides of the innate immunity
M Zanetti
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
An angiogenic role for the human peptide antibiotic LL-37/hCAP-18
R Koczulla et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
In vitro effect on Cryptosporidium parvum of short-term exposure to cathelicidin peptides
A Giacometti et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium
JD Heilborn et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Extracellular ATP is an autocrine/paracrine regulator of hypoxia-induced adventitial fibroblast growth - Signaling through extracellular signal-regulated kinase-1/2 and the Egr-1 transcription factor
EV Gerasimovskaya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis
F Niyonsaba et al.
IMMUNOLOGY (2002)
Antimicrobial peptides of multicellular organisms
M Zasloff
NATURE (2002)
Cutting edge:: The nucleotide receptor P2X7 contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide
LC Denlinger et al.
JOURNAL OF IMMUNOLOGY (2001)
Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus
RA Dorschner et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)
LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells
D Yang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)